Healthcare
Adora Life Science – SUCCESS PAGE – June 11, 2025
Adora Life Science is unlocking the potential of a drug that can slow the progression of degenerative joint disease.
Adora Life Science is unlocking the potential of a drug that can slow the progression of degenerative joint disease.
Adora Life Science is unlocking the potential of a drug that can slow the progression of degenerative joint disease.
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
SQ Innovation has developed a novel drug-device combination for treating fluid overload in adult patients with chronic heart failure
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
SQ Innovation has developed a novel drug-device combination for treating fluid overload in adult patients with chronic heart failure
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
Adora Life Science is unlocking the potential of a drug that stimulates cartilage repair and can slow the progression of degenerative joint disease.
NeuroVision’s AI-driven BrainHealth Platform is redefining how we prevent, diagnose, and treat Alzheimer’s and other neurological conditions
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2025 FORCE Family Office
